House Oversight member demands ’gray marketer’ respond to drug price-gouging probe
A Maryland congressman for a second time is demanding a drug wholesaler answer questions about its handling of one of many lifesaving hospital drugs whose shortages have been disrupting patient care and leading to deaths. Rep. Elijah Cummings, the ranking Democrat on the House Oversight and Government Reform Committee, has been probing alleged price-gouging by secondary suppliers accused of offering scarce drugs at huge markups. Early last month, Cummings demanded information from several so-called "gray marketers" about where they were purchasing the drugs in short supply, what they were paying for them and how much they're charging hospitals.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- TJC Warns Hospitals of Deadly Medical Tubing Mistakes
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- 3 Traits Personality Assessments Can't Reveal
- The secret committee behind our soaring healthcare costs